Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | STTK |
---|---|---|
09:32 ET | 8108 | 3.94 |
09:38 ET | 630 | 4.02 |
09:39 ET | 3201 | 4.07 |
09:41 ET | 200 | 4.07 |
09:43 ET | 1600 | 4.14 |
09:45 ET | 100 | 4.12 |
09:48 ET | 2478 | 4.158 |
09:50 ET | 301 | 4.16 |
09:52 ET | 1801 | 4.15 |
09:54 ET | 100 | 4.15 |
09:56 ET | 3655 | 4.15 |
09:57 ET | 300 | 4.2 |
09:59 ET | 2400 | 4.225 |
10:01 ET | 1463 | 4.22 |
10:03 ET | 2210 | 4.21 |
10:06 ET | 324 | 4.21 |
10:08 ET | 2938 | 4.24 |
10:10 ET | 3200 | 4.29 |
10:12 ET | 500 | 4.28 |
10:14 ET | 2100 | 4.28 |
10:15 ET | 5543 | 4.24 |
10:17 ET | 4848 | 4.29 |
10:19 ET | 2700 | 4.3 |
10:21 ET | 1900 | 4.32 |
10:24 ET | 800 | 4.295 |
10:26 ET | 1810 | 4.33 |
10:28 ET | 2411 | 4.31 |
10:30 ET | 1914 | 4.39 |
10:32 ET | 579 | 4.372 |
10:33 ET | 2323 | 4.39 |
10:35 ET | 2302 | 4.405 |
10:37 ET | 4015 | 4.35 |
10:39 ET | 3423 | 4.35 |
10:42 ET | 716 | 4.34 |
10:44 ET | 1215 | 4.27 |
10:46 ET | 200 | 4.28 |
10:48 ET | 414 | 4.28 |
10:50 ET | 2006 | 4.23 |
10:51 ET | 1100 | 4.18 |
10:53 ET | 300 | 4.18 |
10:55 ET | 700 | 4.13 |
10:57 ET | 200 | 4.13 |
11:00 ET | 300 | 4.09 |
11:02 ET | 2200 | 4.11 |
11:04 ET | 100 | 4.1 |
11:06 ET | 976 | 4.09 |
11:08 ET | 700 | 4.0775 |
11:09 ET | 300 | 4.07 |
11:11 ET | 100 | 4.07 |
11:13 ET | 4232 | 4.08 |
11:15 ET | 4125 | 4.145 |
11:18 ET | 3792 | 4.155 |
11:20 ET | 100 | 4.155 |
11:22 ET | 100 | 4.155 |
11:24 ET | 1600 | 4.155 |
11:26 ET | 2400 | 4.12 |
11:27 ET | 1159 | 4.114 |
11:29 ET | 700 | 4.11 |
11:31 ET | 653 | 4.1 |
11:33 ET | 1999 | 4.08 |
11:36 ET | 2082 | 4.09 |
11:38 ET | 1010 | 4.08 |
11:40 ET | 600 | 4.07 |
11:42 ET | 2000 | 4.08 |
11:44 ET | 200 | 4.08 |
11:45 ET | 300 | 4.07 |
11:47 ET | 2172 | 4.07 |
11:49 ET | 1400 | 4.1 |
11:51 ET | 200 | 4.1 |
11:54 ET | 1358 | 4.1 |
11:56 ET | 200 | 4.1 |
11:58 ET | 1000 | 4.09 |
12:00 ET | 600 | 4.07 |
12:02 ET | 300 | 4.07 |
12:03 ET | 400 | 4.075 |
12:05 ET | 2122 | 4.08 |
12:07 ET | 100 | 4.08 |
12:09 ET | 100 | 4.085 |
12:12 ET | 1500 | 4.07 |
12:14 ET | 3700 | 4.07 |
12:16 ET | 2699 | 4.07 |
12:18 ET | 500 | 4.07 |
12:20 ET | 2401 | 4.08 |
12:21 ET | 200 | 4.08 |
12:23 ET | 600 | 4.08 |
12:25 ET | 400 | 4.07 |
12:27 ET | 300 | 4.07 |
12:30 ET | 1934 | 4.08 |
12:32 ET | 600 | 4.07 |
12:34 ET | 2100 | 4.08 |
12:36 ET | 1355 | 4.09 |
12:38 ET | 300 | 4.09 |
12:39 ET | 300 | 4.1 |
12:41 ET | 2000 | 4.12 |
12:43 ET | 300 | 4.12 |
12:45 ET | 1000 | 4.11 |
12:48 ET | 200 | 4.11 |
12:50 ET | 100 | 4.11 |
12:52 ET | 7605 | 4.17 |
12:56 ET | 2225 | 4.2 |
12:57 ET | 125 | 4.2 |
01:03 ET | 500 | 4.195 |
01:06 ET | 400 | 4.195 |
01:08 ET | 2085 | 4.195 |
01:10 ET | 600 | 4.19 |
01:12 ET | 2484 | 4.22 |
01:14 ET | 300 | 4.215 |
01:15 ET | 200 | 4.215 |
01:17 ET | 1300 | 4.2 |
01:19 ET | 3123 | 4.16 |
01:21 ET | 300 | 4.16 |
01:24 ET | 400 | 4.175 |
01:26 ET | 2150 | 4.21 |
01:28 ET | 100 | 4.205 |
01:30 ET | 100 | 4.19 |
01:32 ET | 200 | 4.2 |
01:33 ET | 800 | 4.21 |
01:35 ET | 200 | 4.21 |
01:37 ET | 2221 | 4.23 |
01:39 ET | 1312 | 4.22 |
01:42 ET | 1100 | 4.19 |
01:44 ET | 200 | 4.19 |
01:46 ET | 500 | 4.2 |
01:48 ET | 100 | 4.2 |
01:50 ET | 1500 | 4.23 |
01:51 ET | 500 | 4.24 |
01:53 ET | 4594 | 4.21 |
01:55 ET | 625 | 4.17 |
01:57 ET | 300 | 4.18 |
02:00 ET | 300 | 4.18 |
02:02 ET | 200 | 4.18 |
02:04 ET | 100 | 4.18 |
02:06 ET | 300 | 4.18 |
02:08 ET | 200 | 4.18 |
02:09 ET | 700 | 4.205 |
02:11 ET | 300 | 4.2 |
02:13 ET | 1103 | 4.2 |
02:15 ET | 800 | 4.18 |
02:18 ET | 200 | 4.18 |
02:20 ET | 300 | 4.19 |
02:22 ET | 100 | 4.18 |
02:24 ET | 300 | 4.19 |
02:26 ET | 100 | 4.19 |
02:27 ET | 300 | 4.18 |
02:29 ET | 1400 | 4.19 |
02:31 ET | 200 | 4.19 |
02:33 ET | 1046 | 4.18 |
02:36 ET | 100 | 4.17 |
02:38 ET | 200 | 4.17 |
02:42 ET | 700 | 4.16 |
02:44 ET | 5080 | 4.13 |
02:45 ET | 1600 | 4.13 |
02:47 ET | 400 | 4.13 |
02:49 ET | 500 | 4.14 |
02:51 ET | 300 | 4.14 |
02:54 ET | 1019 | 4.155 |
02:56 ET | 900 | 4.16 |
02:58 ET | 200 | 4.15 |
03:00 ET | 1066 | 4.15 |
03:02 ET | 100 | 4.16 |
03:03 ET | 300 | 4.15 |
03:05 ET | 600 | 4.17 |
03:07 ET | 1444 | 4.14 |
03:09 ET | 100 | 4.14 |
03:12 ET | 200 | 4.12 |
03:14 ET | 600 | 4.12 |
03:16 ET | 1716 | 4.13 |
03:18 ET | 200 | 4.13 |
03:20 ET | 200 | 4.13 |
03:21 ET | 400 | 4.14 |
03:23 ET | 2010 | 4.13 |
03:25 ET | 100 | 4.14 |
03:27 ET | 600 | 4.15 |
03:30 ET | 425 | 4.13 |
03:32 ET | 8198 | 4.16 |
03:34 ET | 600 | 4.16 |
03:36 ET | 4241 | 4.18 |
03:38 ET | 2216 | 4.17 |
03:39 ET | 300 | 4.19 |
03:41 ET | 3034 | 4.19 |
03:45 ET | 2898 | 4.2099 |
03:48 ET | 3850 | 4.215 |
03:50 ET | 1617 | 4.205 |
03:52 ET | 5135 | 4.2 |
03:54 ET | 2000 | 4.195 |
03:56 ET | 2270 | 4.195 |
03:57 ET | 1506 | 4.195 |
03:59 ET | 9764 | 4.19 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Shattuck Labs Inc | 199.2M | -2.2x | --- |
Inhibrx Biosciences Inc | 192.4M | -2.5x | --- |
Trevi Therapeutics Inc | 197.2M | -8.3x | --- |
Greenwich Lifesciences Inc | 201.3M | -21.7x | --- |
Outlook Therapeutics Inc | 205.5M | -0.8x | --- |
Biomea Fusion Inc | 190.1M | -1.5x | --- |
Shattuck Labs, Inc. is a clinical-stage biotechnology company. The Company is engaged in the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease. Its lead product candidate, SL-172154, is designed to simultaneously inhibit the CD47/SIRPa macrophage checkpoint interaction and activate the CD40 costimulatory receptor to induce an antitumor immune response. It is conducting a Phase IA/B clinical trial in patients with acute myeloid leukemia (AML) and HR-MDS. It has completed the Phase IA dose-escalation portion of this clinical trial and are enrolling patients in the Phase IB expansion cohorts evaluating SL-172154 in combination with azacitidine in frontline HR-MDS or frontline TP53 mutant (TP53m) AML. It has developed the ARC platform to address the need for a single therapeutic that consolidates multiple immune functions.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $199.2M |
---|---|
Revenue (TTM) | $2.7M |
Shares Outstanding | 47.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.75 |
EPS | $-1.93 |
Book Value | $3.06 |
P/E Ratio | -2.2x |
Price/Sales (TTM) | 73.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -3,327.44% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.